
CAS 183871-34-3
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 prodotti.
Ref: 4Z-P-3892
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazine
CAS:Prodotto controllato<p>Applications 2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazine is an impurity of Posaconazole (P689600), which is orally active triazole antifungal.<br>References Cacciapuoti, A., et al.: Antimicrob. Agents Chemother., 44, 2017 (2000); Herbrecht, R., et al.: Int. J. Clin. Pract., 58, 612 (2004); Panackal, A., et al.: J. Clin. Microbiol., 44, 1740 (2006);<br></p>Formula:C12H20N2OColore e forma:NeatPeso molecolare:208.3Ref: ST-EA-CP-P24029
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazine
CAS:<p>2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazine is a human analog that has been found to have anticancer properties. It acts as an inhibitor of kinases, which are enzymes involved in the regulation of cell growth and division. This compound induces apoptosis in Chinese hamster ovary cells and inhibits tumor growth in mice. 2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazine has medicinal potential as a cancer therapy due to its ability to inhibit protein kinases that are involved in the development of cancer cells. This compound may be used as a therapeutic agent for various types of cancer, especially those that are resistant to conventional chemotherapy. It has also been detected in human urine, indicating its potential for use as a diagnostic tool for cancer.</p>Formula:C12H20N2OPurezza:Min. 95%Peso molecolare:208.3 g/mol



